左心室熵是接受除颤器一级预防的扩张型心肌病患者心律失常事件的新型预测因子
本研究基于注册队列,评估了心脏磁共振衍生的左心室熵对扩张型心肌病一级预防植入式心律转复除颤器患者心血管事件的预测价值。中位随访3.2年,左心室熵在包含临床变量和晚期钆增强质量的模型基础上显著改善心律失常事件的预测能力(风险比3.5,95%CI 1.42-8.82,P=0.007)。左心室熵对终末期心力衰竭事件未改善模型预测(风险比2.03,95%CI 0.78-5.28,P=0.14)。
要点
- 左心室熵是心脏磁共振衍生的心肌异质性指标,可预测扩张型心肌病患者心律失常事件。
- 在临床变量和晚期钆增强质量基础上,左心室熵显著改善心律失常事件预测(风险比3.5)。
- 自动左心室熵测量具有优异的观察者内和观察者间一致性。
核心结论
- 自动左心室熵测量是扩张型心肌病患者向室性心律失常风险分层的新型标志物。
研究设计与样本
- 基于注册的队列研究,纳入130例接受一级预防植入式心律转复除颤器的扩张型心肌病患者,在心脏磁共振上测量左心室熵、晚期钆增强存在与否及晚期钆增强质量。
诊断标准与关键数值
- 左心室熵加入包含临床变量和晚期钆增强质量的模型后,心律失常事件风险比3.5(95%CI 1.42-8.82,P=0.007),净重分类指数0.345(P=0.04)。
- 左心室熵对终末期心力衰竭事件未改善包含临床变量和晚期钆增强质量的模型(风险比2.03,95%CI 0.78-5.28,P=0.14)。
- 自动左心室熵测量的观察者内平均差异0.04,观察者间平均差异0.03。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this study was to assess the utility of left ventricular (LV) entropy, a novel measure of myocardial heterogeneity, for predicting cardiovascular events in patients with dilated cardiomyopathy (DCM).
BACKGROUND: Current risk stratification for ventricular arrhythmia in patients with DCM is imprecise. LV entropy is a measure of myocardial heterogeneity derived from cardiac magnetic resonance imaging that assesses the probability distribution of pixel signal intensities in the LV myocardium.
METHODS: A registry-based cohort of primary prevention implantable cardioverter-defibrillator patients with DCM had their LV entropy, late gadolinium enhancement (LGE) presence, and LGE mass measured on cardiac magnetic resonance imaging. Patients were followed from implantable cardioverter-defibrillator placement for arrhythmic events (appropriate implantable cardioverter-defibrillator therapy, ventricular arrhythmia, or sudden cardiac death), end-stage heart failure events (cardiac death, transplantation, or ventricular assist device placement), and all-cause mortality.
RESULTS: One hundred thirty patients (mean age 55 years, 83% men, LV ejection fraction 29%, mean LV entropy 5.58 ± 0.72, LGE present in 57%) were followed for a median of 3.2 years. Eighteen (14.0%) experienced arrhythmic events, 17 (13.1%) experienced end-stage heart failure events, and 7 (5.4%) died. LV entropy provided substantial improvement of predictive ability when added to a model containing clinical variables and LGE mass (hazard ratio: 3.5; 95% confidence interval: 1.42 to 8.82; p = 0.007; net reclassification index = 0.345, p = 0.04). For end-stage heart failure events, LV entropy did not improve the model containing clinical variables and LGE mass (hazard ratio: 2.03; 95% confidence interval: 0.78 to 5.28; p = 0.14). Automated LV entropy measurement has excellent intraobserver (mean difference 0.04) and interobserver (mean difference 0.03) agreement.
CONCLUSIONS: Automated LV entropy measurement is a novel marker for risk stratification toward ventricular arrhythmia in patients with DCM.
引用
- Muthalaly RG, Kwong RY, John RM, et al. Left Ventricular Entropy Is a Novel Predictor of Arrhythmic Events in Patients With Dilated Cardiomyopathy Receiving Defibrillators for Primary Prevention. JACC Cardiovasc Imaging. 2018. PMID: 30121262. doi:10.1016/j.jcmg.2018.07.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。